(PDF) Comparing How Single Arm Phase II Trial Data Can

Comparing How Single Arm Phase II Trial Data Can Support Approval of Oncologics by European Health Technology Assessment Bodies

Value in Health - United Kingdom

doi 10.1016/j.jval.2014.08.2414

Full Text

Abstract

Available in full text

Categories

Occupational Health

Date

November 1, 2014

Authors

Publisher

Elsevier BV

Related search

Evidence for a Lowered Threshold for FDA Approval of Oncologics Based on Single-Arm Phase II Data, Compared to the EMA

Value in Health

Occupational Health

English

Single-Arm Phase II Trial Design Under Parametric Cure Models

Pharmaceutical Statistics

English

Colorectal Liver Metastatic Disease: Efficacy of Irreversible Electroporation—a Single-Arm Phase II Clinical Trial (COLDFIRE-2 Trial)

Cancer Research

English

Optimal Continuous-Monitoring Design of Single-Arm Phase II Trial Based on the Simulated Annealing Method

Contemporary Clinical Trials

English

Reimbursement Approval of Oncology Drugs in Canada Supported by a Data Package Lacking Phase III Trial Data

Value in Health

Occupational Health

English

MS08.01 How Can Real World Data Improve Clinical Evidence Generation and Impact Regulatory Bodies - European Perspective

Journal of Thoracic Oncology

Respiratory Medicine

English

How Politicians’ Reelection Efforts Can Reduce Public Trust, Electoral Support, and Policy Approval

Political Psychology

International Relations

Cognitive Psychology

Clinical Psychology

Political Science

Social Psychology

English

A Single-Arm, Nonrandomized Phase II Trial of Neoadjuvant Gemcitabine and Oxaliplatin in Patients With Resectable Pancreas Adenocarcinoma

Annals of Surgery

English

Meglumine Antimoniate Intralesional Infiltration for Localised Cutaneous Leishmaniasis: A Single Arm, Open Label, Phase II Clinical Trial

Memorias do Instituto Oswaldo Cruz

English